iPSC-based drug discovery services in China — the pharmaceutical industry application of iPSC-derived human cells as more physiologically relevant drug screening systems replacing traditional cancer cell lines and animal models — creates significant commercial market value in the Chinese drug discovery ecosystem, with the China Induced Pluripotent Stem Cells Market reflecting drug...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt